Brentuximab vedotin

Brentuximab vedotin (SGN-35; Adcetris,cAC10-vcMMAE) is an anti-CD30 antibody conjugated via a protease-cleavable linker to the potent anti-microtubule agent monomethyl auristatin E (MMAE). Brentuximab vedotin can be used for the research of relapsed and refractory Hodgkin lymphoma.
Supplier Selleck Chemicals
Product # D4045
Sku # D4045-1mg
Pricing 1mg, $970.00
Feedback